These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 25888377

  • 1. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X, Jin W, Jia H, Yan J, Zhang G.
    J Exp Clin Cancer Res; 2015 Mar 26; 34(1):28. PubMed ID: 25888377
    [Abstract] [Full Text] [Related]

  • 2. The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.
    Eto K, Iwatsuki M, Watanabe M, Ishimoto T, Ida S, Imamura Y, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Baba H.
    Int J Cancer; 2015 Apr 01; 136(7):1537-45. PubMed ID: 25159729
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J, Cui Z, Li L, Ma Q, Wang Q, Gao Y, Sun H.
    Tumour Biol; 2015 Sep 01; 36(10):7831-40. PubMed ID: 25944166
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
    Zhu M, Zhou X, Du Y, Huang Z, Zhu J, Xu J, Cheng G, Shu Y, Liu P, Zhu W, Wang T.
    Mol Med Rep; 2016 Aug 01; 14(2):1742-50. PubMed ID: 27357419
    [Abstract] [Full Text] [Related]

  • 8. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
    Zhou C, Shen L, Mao L, Wang B, Li Y, Yu H.
    Biochem Biophys Res Commun; 2015 Feb 27; 458(1):63-9. PubMed ID: 25623537
    [Abstract] [Full Text] [Related]

  • 9. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
    Wen L, Cheng F, Zhou Y, Yin C.
    Saudi J Gastroenterol; 2015 Feb 27; 21(5):313-9. PubMed ID: 26458859
    [Abstract] [Full Text] [Related]

  • 10. MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G₁/S transition and apoptosis by targeting p21(WAF1/CIP1).
    Wang H, Zhu LJ, Yang YC, Wang ZX, Wang R.
    Br J Cancer; 2014 Jul 15; 111(2):339-54. PubMed ID: 24921914
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z, Kong Y, Yang W, Ma F, Zhang Y, Ji S, Ma EM, Liu H, Chen Y, Hua Y.
    Oncol Rep; 2016 Oct 15; 36(4):2391-7. PubMed ID: 27513895
    [Abstract] [Full Text] [Related]

  • 15. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M, Shan X, Zhou X, Qiu T, Zhu W, Ding Y, Shu Y, Liu P.
    Anticancer Agents Med Chem; 2014 Oct 15; 14(6):884-91. PubMed ID: 24875127
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J, Xue X, Hong H, Qin M, Zhou J, Sun Q, Liang H, Gao L.
    Oncotarget; 2017 Jan 03; 8(1):574-582. PubMed ID: 27880941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J, Xu Y, Wang Q, Zhang J, Li Z, Li D, Li J.
    Biomed Pharmacother; 2017 Aug 03; 92():1030-1037. PubMed ID: 28609840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.